4 citations,
January 2024 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.